IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
about
SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokinesThe biology and mechanism of action of suppressor of cytokine signaling 3The future of EPAC-targeted therapies: agonism versus antagonismSOCS, Inflammation, and Autoimmunity.Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic CellsAssociation between IL-6 concentration and diabetes-related variables in DM1 patients with and without microvascular complicationsMyeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.SOCS3, a Major Regulator of Infection and Inflammation.Inhibition of IL-6 family cytokines by SOCS3.A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts.Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.The protein kinase C inhibitor, Ro-31-7459, is a potent activator of ERK and JNK MAP kinases in HUVECs and yet inhibits cyclic AMP-stimulated SOCS-3 gene induction through inactivation of the transcription factor c-Jun.Insights into gene expression profiles induced by Socs3 depletion in keratinocytes.The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation.Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
P2860
Q26853718-56E260BC-BB1F-486B-85D3-6BCA96B462BDQ27003933-9A26D1A7-6E88-4595-94C6-FCB0D4697A5AQ34465923-E8947CAF-3A68-40F1-B8D1-85084E8609D2Q35927538-65B27E3C-CAF8-4DB4-AE2C-6096CD99B22EQ36119606-760681B3-700F-402E-94EC-8030900C9E0AQ36828612-4FC86AAE-1054-4EF3-8B64-8CCF414FB7A5Q37022886-414CC5B3-D5C5-45FE-BD2F-97CD9E4D9E36Q37111982-657E4759-D093-4C8F-83A0-3EBD7C3FA11FQ37592325-046E9289-8B0A-4ABA-9D2C-9F3E689BFCB5Q37676036-70BD5CE6-7FE5-4CEC-9A6F-B06872714925Q39157245-AEB079CE-46AC-4876-A865-D9FF62B86250Q41788599-066AFF30-B1DB-4BC8-B36C-82DBC7634BDAQ42216011-37740BBE-42D7-4D27-A195-F43AE25F9BF9Q46602150-32D1815E-03BB-4CEE-A143-D5B6352DB333Q48172039-BB8412AA-25BB-41A4-9877-73F0E8881116Q51776133-2569EB7B-1869-47F1-AE93-199FE4444001
P2860
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
@ast
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
@en
type
label
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
@ast
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
@en
prefLabel
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
@ast
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
@en
P2093
P2860
P50
P356
P1476
IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.
@en
P2093
Louise H Cengia
Warren S Alexander
P2860
P2888
P304
P356
10.1038/ICB.2011.29
P50
P577
2011-04-26T00:00:00Z
P5875
P6179
1041689941